196 related articles for article (PubMed ID: 36608925)
1. Reduced specificity for the local lymph node assay for lipophilic chemicals: Implications for the validation of new approach methods for skin sensitization.
Natsch A; Kleinstreuer N; Asturiol D
Regul Toxicol Pharmacol; 2023 Feb; 138():105333. PubMed ID: 36608925
[TBL] [Abstract][Full Text] [Related]
2. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
[TBL] [Abstract][Full Text] [Related]
3. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
4. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
6. A triangular approach for the validation of new approach methods for skin sensitization.
Natsch A; Landsiedel R; Kolle SN
ALTEX; 2021; 38(4):669-677. PubMed ID: 34247252
[TBL] [Abstract][Full Text] [Related]
7. Activity of human contact allergens in the murine local lymph node assay.
Ryan CA; Gerberick GF; Cruse LW; Basketter DA; Lea L; Blaikie L; Dearman RJ; Warbrick EV; Kimber I
Contact Dermatitis; 2000 Aug; 43(2):95-102. PubMed ID: 10945748
[TBL] [Abstract][Full Text] [Related]
8. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
9. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
Roberts DW; Schultz TW; Api AM
Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
[TBL] [Abstract][Full Text] [Related]
10. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
11. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
[TBL] [Abstract][Full Text] [Related]
12. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
13. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
[TBL] [Abstract][Full Text] [Related]
14. The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test.
Basketter DA; Scholes EW; Kimber I
Food Chem Toxicol; 1994 Jun; 32(6):543-7. PubMed ID: 8045461
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the local lymph node assay (LLNA) for skin sensitisation.
Roberts DW; Kimber I; Basketter DA
Regul Toxicol Pharmacol; 2023 Jun; 141():105402. PubMed ID: 37116738
[TBL] [Abstract][Full Text] [Related]
16. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Chen W; Xing C; Hou F
J Pharmacol Toxicol Methods; 2016; 82():26-30. PubMed ID: 27456929
[TBL] [Abstract][Full Text] [Related]
17. Local lymph node assay: use in hazard and risk assessment.
Dearman RJ; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(5):299-306. PubMed ID: 10513674
[TBL] [Abstract][Full Text] [Related]
18. Local lymph node assay: validation assessment for regulatory purposes.
Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
[TBL] [Abstract][Full Text] [Related]
19. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
[TBL] [Abstract][Full Text] [Related]
20. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
